0001104659-22-033453.txt : 20220314 0001104659-22-033453.hdr.sgml : 20220314 20220314183211 ACCESSION NUMBER: 0001104659-22-033453 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220310 FILED AS OF DATE: 20220314 DATE AS OF CHANGE: 20220314 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Miller Steven Clive CENTRAL INDEX KEY: 0001883325 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40825 FILM NUMBER: 22738128 MAIL ADDRESS: STREET 1: C/O WARBY PARKER INC. STREET 2: 233 SPRING STREET, 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10013 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Warby Parker Inc. CENTRAL INDEX KEY: 0001504776 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] IRS NUMBER: 800423634 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 233 SPRING STREET STREET 2: 6TH FLOOR EAST CITY: NEW YORK STATE: NY ZIP: 10013 BUSINESS PHONE: (646) 847-7215 MAIL ADDRESS: STREET 1: 233 SPRING STREET STREET 2: 6TH FLOOR EAST CITY: NEW YORK STATE: NY ZIP: 10013 FORMER COMPANY: FORMER CONFORMED NAME: JAND, Inc. DATE OF NAME CHANGE: 20101102 4 1 tm229170-3_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-03-10 0 0001504776 Warby Parker Inc. WRBY 0001883325 Miller Steven Clive C/O WARBY PARKER INC., 233 SPRING STREET, 6TH FLOOR EAST NEW YORK NY 10013 0 1 0 0 Chief Financial Officer Class A Common Stock 2022-03-10 4 M 0 13463 0 A 170907 D Class A Common Stock 2022-03-10 4 S 0 5767 25.00 D 165140 D Class A Common Stock 2022-03-11 4 S 0 6949 24.4335 D 158191 D Class A Common Stock 2022-03-11 4 S 0 747 25.0455 D 157444 D Restricted Stock Units 2022-03-10 4 M 0 1981 0 D Class A Common Stock 1981 23112 D Restricted Stock Units 2022-03-10 4 M 0 1326 0 D Class A Common Stock 1326 0 D Restricted Stock Units 2022-03-10 4 M 0 2525 0 D Class A Common Stock 2525 19358 D Restricted Stock Units 2022-03-10 4 M 0 2535 0 D Class A Common Stock 2535 9294 D Restricted Stock Units 2022-03-10 4 M 0 5096 0 D Class A Common Stock 5096 69643 D This filing relates to the occurrence of a RSU vesting event. Sale of shares to cover taxes due on restricted stock units that vested, as mandated by the Issuer's equity compensation plan. The sales reported were effected pursuant to a 10b5-1 trading plan adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.96 to $24.90. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.99 to $25.15. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Each Restricted Stock Unit represents a contingent right to receive one share of the Company's Class A Common Stock. The restricted stock units will vest in 48 monthly installments beginning on January 1, 2021 and will expire on January 27, 2028. The restricted stock units will vest in 48 monthly installments beginning on January 1, 2018 and will expire on October 16, 2025. The restricted stock units will vest in 48 monthly installments beginning on January 1, 2020 and will expire on November 19, 2026. The restricted stock units will vest in 48 monthly installments beginning on January 1, 2019 and will expire on March 28, 2026. The restricted stock units will vest in 48 monthly installments beginning on July 1, 2021 and will expire on June 14, 2031. /s/ Hyung Bak, Attorney-in-Fact 2022-03-14